In the meeting, the investment which is more concerned about the issue was answered, here collated the company's recent research report and investor relations activities in the table of record, can let you have an intuitive understanding of the company Izumi.
The company is mainly engaged in "molding" special machinery and equipment business, at present the main injection molding machine and die-casting machine, the two business accounted for more than 90%.
Injection molding machine downstream is mainly 3C, home appliances, medical, packaging, 5G plastic structural parts, etc., in the epidemic after the impact of the relevant demand for faster recovery.
Die casting machine downstream mainly more than 70% of the application is automobile, last year 3 quarter started, the industry of automobile ring rebound, home appliances and cell phone market performance is good.
From the external point of view, at present the company's main products injection molding machine and die casting machine on hand orders are sufficient.
From the internal point of view, the company relies on several aspects, the development has been better than the industry average:
1, R & D-driven, and constantly improve the product range, such as the company has introduced to the market of large-scale two-platen injection molding machine, all-electric injection molding machine, high-end multi-material injection molding machine;
2, the shift in operational strategy, from providing customers with the mainframe to the provision of a complete set of applications solutions for the Rapid transformation;
3, globalization layout, currently there are more than 40 overseas distributors, covering more than 70 countries, and has a number of overseas factories and R & D centers.
Specifically from time to time, 20 years 1 quarter performance is still a loss, 2, 3 quarter, revenue and profit on the company's record high since its inception, according to the performance forecast, the 4 quarter revenue of 860 million, continue to record highs, an increase of 74%.
Internal management, see the company landed in November 19 injection molding machine lean production line, the bulk componentization, shorten the design cycle, but also shorten the total assembly cycle.
Through the performance of this year to see, the adoption of lean production mode, improve production efficiency, reduce inventory, and effectively improve the utilization of injection molding machine production plant.
In the future, the company will extend the lean production line for injection molding machines to other divisions to further improve the company's production efficiency.
At present, the company also has a 180 million fixed increase, has been registered through the Securities and Exchange Commission, has not yet been implemented,
The company's performance forecast, basically the upper limit of the pre-brokerage research report, predicted that the average value of 21 years of profits is 410 million, according to the 25 times the P/E ratio to see words. Valuation at about 10 billion, the current company valuation of about 7.5 billion.
Personal analysis, only for the exchange, does not constitute investment advice. According to this sale, the consequences of their own responsibility.